None listed
Conditions
Brief summary
Currently, standard practice for any snake bite requires laboratory testing to determine if a patient has been envenomed, and coagulation studies are the most important tests. The administration of antivenom is then based on the presence of clinical effects of envenoming and abnormal laboratory investigations. However, many of these envenoming effects are irreversible, so once they develop they are unlikely to be reversed by antivenom. In this case, antivenom needs to be given prior to the development of abnormal laboratory test or clinical effects. The aim of this project will be to administer antivenom early – as soon as the patient presents to hospital, without first waiting for laboratory tests or the development of clinical signs of envenoming, and/or retrieval to a major hospital. The objective is to prevent envenoming effects that may lead to significant morbidity or death.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
1. Presents to hospital within 2 hours of snakebite 2. Definite sighting of a snake by the patient (or parent/carer of child, age >2years) and a confirmed bite. 3. Early non-specific systemic symptoms suggesting envenoming: EITHER: collapse OR two of vomiting, headache, diarrhoea or abdominal pain.
Exclusion criteria
1. Aged under 2 years of age 2. Definite bite by a non-venomous snake 3. Definite bite by a red-bellied black snake at hospitals where a separate study is being undertaken (Hunter Area Health Hospitals, Manning Base Hospital, Coffs Harbour Hospital, Liverpool Hospital, Campbelltown Hospital) 4. Suspected taipan bites (in northern regions of Australia where taipans occur) 5. Cases consistent with mulga snake envenoming 6. Cases consistent with death adder envenoming 7. Cardiac Arrest.